Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Seres Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 123 | 138 | +15 |
| Shares | 104.7M | 112.3M | +7.57M (+7.2%) |
| Value | $593.9M | $538.1M | −$55.9M (−9.4%) |
New holders (36)
Institutions that held Seres Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (21)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Kynam Capital Management, LP | 768,913 | $4.36M |
| Renaissance Technologies LLC | 398,200 | $2.26M |
| Walleye Capital LLC | 362,324 | $2.05M |
| Silverarc Capital Management, LLC | 232,525 | $1.32M |
| Atom Investors LP | 90,388 | $512.5K |
| Advisory Research Inc | 73,553 | $417.0K |
| Tudor Investment Corp Et Al | 66,595 | $378.0K |
| Hennion & Walsh Asset Management, Inc. | 61,090 | $346.0K |
| HRT Financial LP | 58,661 | $332.0K |
| SG Americas Securities, LLC | 43,684 | $248.0K |
| Group One Trading, L.P. | 30,094 | $170.6K |
| Fox Run Management, L.L.C. | 16,448 | $93.3K |
| Nebula Research & Development LLC | 11,893 | $67.4K |
| Walleye Trading LLC | 10,198 | $57.8K |
| Quadrant Capital Group LLC | 2,101 | $11.9K |
| Orion Capital Management LLC | 1,000 | $5.67K |
| Crewe Advisors LLC | 676 | $3.83K |
| Signaturefd, LLC | 339 | $1.92K |
| US Bancorp | 175 | $992 |
| Grey Fox Wealth Advisors, LLC | 100 | $567 |
| Belpointe Asset Management LLC | 49 | $278 |